Infliximab Biosimilar for Intravenous Drip Infusion 100 mg " Pfizer " Drug Use Investigation (Rheumatoid Arthritis)
Condition: Rheumatoid Arthritis Intervention: Drug: Infliximab [infliximab biosimilar 3] Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials